Received Sep 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
never completed the series, now wants the third dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (first dose of Twinrix in Sep 2022 (4F3YY expiry date 01 Jan 2023),) and Twinrix (second dose in Oct 2022). On an unknown date, the patient received the 3rd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: never completed the series, now wants the third dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-AUG-2025 Pharmacist called to report that patient got first dose of Twinrix in Sep 2022 and the second dose in Oct 2022 but never received the third dose. Now the patient wants the third dose. Till the time of reporting, the patient did not receive 3rd dose of Twinrix, which led to incomplete course of vaccination.